Cargando…
Association between adjuvant therapy and survival in colorectal cancer patients according to metabolic Warburg-subtypes
PURPOSE: Tumor location and tumor node metastasis (TNM) stage guide treatment decisions in colorectal cancer (CRC) patients. However, patients with the same disease stage do not benefit equally from adjuvant therapy. Hence, there remains an urgent clinical need to identify prognostic and/or predicti...
Autores principales: | Offermans, Kelly, Jenniskens, Josien C. A., Simons, Colinda C. J. M., Samarska, Iryna, Fazzi, Gregorio E., Smits, Kim M., Schouten, Leo J., Weijenberg, Matty P., Grabsch, Heike I., van den Brandt, Piet A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356897/ https://www.ncbi.nlm.nih.gov/pubmed/36723668 http://dx.doi.org/10.1007/s00432-023-04581-w |
Ejemplares similares
-
Expression of proteins associated with the Warburg‐effect and survival in colorectal cancer
por: Offermans, Kelly, et al.
Publicado: (2021) -
Association between mutational subgroups, Warburg‐subtypes, and survival in patients with colorectal cancer
por: Offermans, Kelly, et al.
Publicado: (2022) -
Energy balance‐related factors in childhood and adolescence and risk of colorectal cancer expressing different levels of proteins involved in the Warburg‐effect
por: Jenniskens, Josien C. A., et al.
Publicado: (2022) -
Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status
por: Jenniskens, Josien C. A., et al.
Publicado: (2022) -
Energy balance‐related factors in childhood and adolescence and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status
por: Jenniskens, Josien C. A., et al.
Publicado: (2022)